A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: ocular (67), optical (6)

Erdafitinib

Description
Regimen • Urothelial - Erdafitinib Chemotherapy Protocol UROTHELIAL CANCER ERDAFITINIB Indication • Monotherapy treatment of unresectable or metastatic urothelial cancer harbouring a susceptible fibrobla
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Erdafitinib.pdf

Brigatinib

Description
Chemotherapy Protocol Lung Cancer Regimen Brigatinib • NSCLC – Brigatinib Indication • Brigatinib is indicated as monotherapy f
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Brigatinib.pdf

Lazy eye in children - patient information

Description
This factsheet contains information about the two most common treatment options for a lazy eye.
Url
/Media/UHS-website-2019/Patientinformation/Eyes/Childrens-eyes/Lazy-eye-in-children-1783-PIL.pdf

Binimetinib-Encorafenib

Description
Chemotherapy Protocol SKIN CANCER Binimetinib-Encorafenib Regimen • Skin – Binimetinib-Encorafenib Indication • Unresectable or me
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Binimetinib-Encorafenib.pdf

Evoked potentials - patient information

Description
This factsheet explains what evoked potential (EP) tests are and what will happen at your appointment, so you know how to
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/Evoked-potentials-1650-PIL.pdf

Dr Helena Lee, associate director for emerging therapies

Description
Auto Generated Title Email: Helena.Lee@uhs.nhs.uk Dr Lee is an MRC Clinician Scientist Fellow and Associate Professor in Opht
Url
/ClinicalResearchinSouthampton/Our-people/Clinical-research-facility-people/Dr-Helena-Lee-associate-director-for-emerging-therapies.aspx

Pemigatinib

Description
Chemotherapy Protocol CHOLANGIOCARCINOMA PEMIGATINIB Regimen  Cholangiocarcinoma - Pemigatinib Indication Pemigatinib for locally advanced or metastatic cholangioca
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Pemigatinib.pdf

Headache diary 2025 - version 3.0

Description
Headache diary Tip: Keep it simple. Avoid writing more than one headache severity for each day. To gauge the effect of treatment, it is th
Url
/Media/UHS-website-2019/Docs/headache-diary-2025-version-3.0.docx

Annual-report-and-quality-account-2019-20

Description
ANNUAL REPORT AND ACCOUNTS 2019/20 Incorporating the quality account 2019/20 Page 2 University Hospital Southampton NHS Foundation Trust Annual
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-and-quality-account-2019-202.pdf

Dabrafenib Trametinib Ver1

Description
Chemotherapy Protocol SKIN CANCER DABRAFENIB-TRAMETINIB Regimen  Skin – Dabrafenib-Trametinib Indication  The combination of dabrafenib and trametinib is recommended as an option for the first lin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibTrametinibVer1.pdf
11 to 20 of 72
Previous 1 2 3 4 5 … Next